D-sh-Buforin

General Information


DRACP ID  DRACP04095

Peptide Name   D-sh-Buforin

Sequence  raGlqfpvGrvhrllrk

Sequence Length  17

UniProt ID  P55897 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C4H-22N2O-12

Absent amino acids  ACDEFHIKLMNPQRSTVWY

Common amino acids  G

Mass  14744

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  188

Hydrophobicity  -4.71

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30141623

Title  Phagosomal Copper-Promoted Oxidative Attack on Intracellular Mycobacterium tuberculosis

Doi Not available

Year  2018

Literature 2

Pubmed ID 25891844

Title  Hybrid peptide ATCUN-sh-Buforin: Influence of the ATCUN charge and stereochemistry on antimicrobial activity

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17033

DRACP is developed by Dr.Zheng's team.